← Open Payments lookup

LYNETTE MOON: Open Payments

NPI 1598131278 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,937 in 91 payments from 17 companies in 2025. Trend: 2023 $1,268 · 2024 $1,412 · 2025 $1,937

Food & beverage: $1,937
CompanyPaymentsAmount
Janssen Biotech, Inc.8$393
ABBVIE INC.18$329
Takeda Pharmaceuticals U.S.A., Inc.12$252
Madrigal Pharmaceuticals15$180
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$136
GENZYME CORPORATION3$112
QOL Medical, LLC5$96
Celltrion USA Inc.4$75
Aimmune Therapeutics, Inc.3$74
Lilly USA, LLC4$66

Products named: TREMFYA, REZDIFFRA, RINVOQ, ENTYVIO, XIFAXAN, DUPIXENT, Sucraid, EOHILIA.

Industry payments across IN — which companies pay providers there.